| Original language | English |
|---|---|
| Pages (from-to) | 3676-3679 |
| Number of pages | 4 |
| Journal | Allergy: European Journal of Allergy and Clinical Immunology |
| Volume | 77 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2022 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, No. 12, 12.2022, p. 3676-3679.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma
AU - Kim, Josh G.
AU - Zhang, Ai
AU - Rauseo, Adriana M.
AU - Goss, Charles W.
AU - Mudd, Philip A.
AU - O'Halloran, Jane A.
AU - Wang, Leyao
N1 - Funding Information: We would like to thank all the study participants. We thank Dr. Maya Jerath, Dr. Zhen Ren, Dr. Andrew Kau, and Dr. James Krings (all at Washington University in St. Louis School of Medicine) for critical advice on the asthma medication. We thank Lijuan Cao and Mansi Agarwal (both at Washington University in St. Louis School of Medicine) for their assistance with data analyses. This work was supported by the National Institutes of Health (grant number 5R21AI139649-02 to L.W.). This study utilized samples obtained from the Washington University School of Medicine's COVID-19 biorepository, which was supported by the Barnes-Jewish Hospital Foundation, Siteman Cancer Center grant P30 CA091842 from the National Cancer Institute of the National Institutes of Health, and Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the view of the NIH. Funding Information: We would like to thank all the study participants. We thank Dr. Maya Jerath, Dr. Zhen Ren, Dr. Andrew Kau, and Dr. James Krings (all at Washington University in St. Louis School of Medicine) for critical advice on the asthma medication. We thank Lijuan Cao and Mansi Agarwal (both at Washington University in St. Louis School of Medicine) for their assistance with data analyses. This work was supported by the National Institutes of Health (grant number 5R21AI139649‐02 to L.W.). This study utilized samples obtained from the Washington University School of Medicine's COVID‐19 biorepository, which was supported by the Barnes‐Jewish Hospital Foundation, Siteman Cancer Center grant P30 CA091842 from the National Cancer Institute of the National Institutes of Health, and Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the view of the NIH.
PY - 2022/12
Y1 - 2022/12
UR - http://www.scopus.com/inward/record.url?scp=85134540498&partnerID=8YFLogxK
U2 - 10.1111/all.15438
DO - 10.1111/all.15438
M3 - Letter
C2 - 35837881
AN - SCOPUS:85134540498
SN - 0105-4538
VL - 77
SP - 3676
EP - 3679
JO - Allergy: European Journal of Allergy and Clinical Immunology
JF - Allergy: European Journal of Allergy and Clinical Immunology
IS - 12
ER -